Development and Validation of a Discriminating <Emphasis Type="Italic">In Vitro</Emphasis> Dissolution Method for a Poorly Soluble Drug,Olmesartan Medoxomil: Comparison Between Commercial Tablets |
| |
Authors: | Lisiane Bajerski Rochele Cassanta Rossi Carolina Lupi Dias Ana Maria Bergold Pedro Eduardo Fröehlich |
| |
Institution: | Programa de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul (UFRGS), Av. Ipiranga, 2752, CEP 90610-000 Porto Alegre, RS Brazil |
| |
Abstract: | A dissolution test for tablets containing 40 mg of olmesartan medoxomil (OLM) was developed and validated using both LC-UV
and UV methods. After evaluation of the sink condition, dissolution medium, and stability of the drug, the method was validated using USP apparatus 2, 50 rpm rotation
speed, and 900 ml of deaerated H2O + 0.5% sodium lauryl sulfate (w/v) at pH 6.8 (adjusted with 18% phosphoric acid) as the dissolution medium. The model-independent method using difference factor
(f
1) and similarity factor (f
2), model-dependent method, and dissolution efficiency were employed to compare dissolution profiles. The kinetic parameters
of drug release were also investigated. The obtained results provided adequate dissolution profiles. The developed dissolution
test was validated according to international guidelines. Since there is no monograph for this drug in tablets, the dissolution
method presented here can be used as a quality control test for OLM in this dosage form, especially in a batch to batch evaluation. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|